The prevalence and correlated risk factors of arrhythmia in patients with chronic systolic heart failure

Objective To investigate the prevalence of arrhythmia in patients with chronic systolic heart failure (CSHF) in Hubei province and analyse the correlation between atrial fibrillation (AF), premature ventricular contracts (PVCs), ventricular tachycardia (VT) and age, NYHA heart function classificatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2011-10, Vol.97 (Suppl 3), p.A220-A221
1. Verfasser: Shengbo, Yu
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A221
container_issue Suppl 3
container_start_page A220
container_title Heart (British Cardiac Society)
container_volume 97
creator Shengbo, Yu
description Objective To investigate the prevalence of arrhythmia in patients with chronic systolic heart failure (CSHF) in Hubei province and analyse the correlation between atrial fibrillation (AF), premature ventricular contracts (PVCs), ventricular tachycardia (VT) and age, NYHA heart function classification, left ventricular ejection fraction (LVEF), aetiology, respectively. Methods Data of in-hospital patients with CSHF were investigated between 2000 and 2010 from 12 hospitals in Hubei Province. Univariate and multivariate logistic proportional hazard analysis were performed to determinate the relationships between AF, PVCs, VT and age, NYHA heart function classification, LVEF, aetiology, respectively. Results (1) PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF which account 68.30%, 40.81%, 21.16% and 14.50%, respectively. (2) The HRs (95% CI) of AF for patients in 40–50, 50–60, 60–70, 70–80 and ≥80 age were 1.670 (1.237 to 2.253, p
doi_str_mv 10.1136/heartjnl-2011-300867.646
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1780718553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4020986811</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2646-925e39288f5270bfae73de92ed18a3b052dcadc2f8c88d6c749be812398688573</originalsourceid><addsrcrecordid>eNqNUMtu2zAQFIoEaOL0Hwj0rJQP8aFja6RJAKPpwUl7IyhqBdGRJXdJJ_Hfh66anHvawWJmZ3aKgjB6yZhQX3pwmDbjUHLKWCkoNUpfqkp9KM5Ypcxx_fskYyFlqajQH4vzGDeU0qo26qzo1z2QHcKTG2D0QNzYEj8hwuAStARDfCSd82nCSKaOOMT-kPptcCSMZOdSgDFF8hxST3yP0xg8iYeYpiGDv9GyOgx7hIvitHNDhE__5qK4_361Xt6Uq7vr2-XXVdnwnLqsuQRRc2M6yTVtOgdatFBzaJlxoqGSt961nnfGG9Mqr6u6AcO4yN8YI7VYFJ_nuzuc_uwhJruZ9jhmS8u0oZoZKUVmmZnlcYoRobM7DFuHB8uoPfZq33q1x17t3KvNCbO0nKUhJnh51zl8tEoLLe2Ph6Wt1fr65-pXZb9lvpj5zXbz_y6vJ42O_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780718553</pqid></control><display><type>article</type><title>The prevalence and correlated risk factors of arrhythmia in patients with chronic systolic heart failure</title><source>BMJ Journals - NESLi2</source><source>PubMed Central</source><creator>Shengbo, Yu</creator><creatorcontrib>Shengbo, Yu</creatorcontrib><description><![CDATA[Objective To investigate the prevalence of arrhythmia in patients with chronic systolic heart failure (CSHF) in Hubei province and analyse the correlation between atrial fibrillation (AF), premature ventricular contracts (PVCs), ventricular tachycardia (VT) and age, NYHA heart function classification, left ventricular ejection fraction (LVEF), aetiology, respectively. Methods Data of in-hospital patients with CSHF were investigated between 2000 and 2010 from 12 hospitals in Hubei Province. Univariate and multivariate logistic proportional hazard analysis were performed to determinate the relationships between AF, PVCs, VT and age, NYHA heart function classification, LVEF, aetiology, respectively. Results (1) PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF which account 68.30%, 40.81%, 21.16% and 14.50%, respectively. (2) The HRs (95% CI) of AF for patients in 40–50, 50–60, 60–70, 70–80 and ≥80 age were 1.670 (1.237 to 2.253, p<0.01), 2.315 (1.759 to 3.047, p<0.01), 3.103 (2.368 to 4.067, p<0.01), 3.805 (2.911 to 4.972, p<0.01) and 5.018 (3.771 to 6.676, p<0.01), respectively, compared with patients in <40 years group. While there were no significant difference among different age groups in HR of PVCs and VT in multivariate logistic analysis. (3) The HRs (95% CI) of AF or VT for patients in LVEF 31–40%, 21–30% and ≤20% group were 1.565 (1.446 to 1.717, p<0.01), 1.640 (1.225 to 1.923, p<0.01) and 2.104 (1.925 to 2.223, p<0.01), respectively; 1.760 (95% CI 1.218 to 2.345, p<0.01), 2.396 (95% CI 2.019 to 2.783, p<0.01) and 4.209 (95% CI 3.554 to 4.862, p<0.01), respectively, compared with patients in LVEF 41–50% group. However, there is no significant difference among different LVEF groups in HR of PVCs in multivariate logistic analysis. (4) The HRs (95% CI) of AF, PVCs and VT for patients with dilated cardiomyopathy, hypertension heart disease or valvular heart disease were 1.876 (1.608 to 2.188, p<0.01), 1.297 (1.132 to 1.486, p<0.01) and 12.111 (9.820 to 14.937, p<0.01), respectively; 1.143 (1.082 to 1.224, p<0.01), 0.559 (0.322 to 0.743, p<0.01) and 0.896 (0.775 to 1.211, p=0.358), respectively; 1.189 (95% CI 1.096 to 1.284, p<0.01), 0.430 (95% CI 0.381 to 0.497, p<0.01) and 0.530 (95% CI 0.421 to 0.652, p<0.01), respectively, compared with patients in coronary heart disease group. Conclusions PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF. The risk of AF morbidity increases as age increases or LVEF decreases and varies in patients with different aetiology. The risk of PVCs morbidity varies in patients with different aetiology while was not affected by age, NYHA or LVEF. The risk of VT morbidity increases as LVEF decreases and is different in patients with different aetiology.]]></description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/heartjnl-2011-300867.646</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><ispartof>Heart (British Cardiac Society), 2011-10, Vol.97 (Suppl 3), p.A220-A221</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b2646-925e39288f5270bfae73de92ed18a3b052dcadc2f8c88d6c749be812398688573</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://heart.bmj.com/content/97/Suppl_3/A220.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://heart.bmj.com/content/97/Suppl_3/A220.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3182,23551,27903,27904,77346,77377</link.rule.ids></links><search><creatorcontrib>Shengbo, Yu</creatorcontrib><title>The prevalence and correlated risk factors of arrhythmia in patients with chronic systolic heart failure</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description><![CDATA[Objective To investigate the prevalence of arrhythmia in patients with chronic systolic heart failure (CSHF) in Hubei province and analyse the correlation between atrial fibrillation (AF), premature ventricular contracts (PVCs), ventricular tachycardia (VT) and age, NYHA heart function classification, left ventricular ejection fraction (LVEF), aetiology, respectively. Methods Data of in-hospital patients with CSHF were investigated between 2000 and 2010 from 12 hospitals in Hubei Province. Univariate and multivariate logistic proportional hazard analysis were performed to determinate the relationships between AF, PVCs, VT and age, NYHA heart function classification, LVEF, aetiology, respectively. Results (1) PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF which account 68.30%, 40.81%, 21.16% and 14.50%, respectively. (2) The HRs (95% CI) of AF for patients in 40–50, 50–60, 60–70, 70–80 and ≥80 age were 1.670 (1.237 to 2.253, p<0.01), 2.315 (1.759 to 3.047, p<0.01), 3.103 (2.368 to 4.067, p<0.01), 3.805 (2.911 to 4.972, p<0.01) and 5.018 (3.771 to 6.676, p<0.01), respectively, compared with patients in <40 years group. While there were no significant difference among different age groups in HR of PVCs and VT in multivariate logistic analysis. (3) The HRs (95% CI) of AF or VT for patients in LVEF 31–40%, 21–30% and ≤20% group were 1.565 (1.446 to 1.717, p<0.01), 1.640 (1.225 to 1.923, p<0.01) and 2.104 (1.925 to 2.223, p<0.01), respectively; 1.760 (95% CI 1.218 to 2.345, p<0.01), 2.396 (95% CI 2.019 to 2.783, p<0.01) and 4.209 (95% CI 3.554 to 4.862, p<0.01), respectively, compared with patients in LVEF 41–50% group. However, there is no significant difference among different LVEF groups in HR of PVCs in multivariate logistic analysis. (4) The HRs (95% CI) of AF, PVCs and VT for patients with dilated cardiomyopathy, hypertension heart disease or valvular heart disease were 1.876 (1.608 to 2.188, p<0.01), 1.297 (1.132 to 1.486, p<0.01) and 12.111 (9.820 to 14.937, p<0.01), respectively; 1.143 (1.082 to 1.224, p<0.01), 0.559 (0.322 to 0.743, p<0.01) and 0.896 (0.775 to 1.211, p=0.358), respectively; 1.189 (95% CI 1.096 to 1.284, p<0.01), 0.430 (95% CI 0.381 to 0.497, p<0.01) and 0.530 (95% CI 0.421 to 0.652, p<0.01), respectively, compared with patients in coronary heart disease group. Conclusions PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF. The risk of AF morbidity increases as age increases or LVEF decreases and varies in patients with different aetiology. The risk of PVCs morbidity varies in patients with different aetiology while was not affected by age, NYHA or LVEF. The risk of VT morbidity increases as LVEF decreases and is different in patients with different aetiology.]]></description><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNUMtu2zAQFIoEaOL0Hwj0rJQP8aFja6RJAKPpwUl7IyhqBdGRJXdJJ_Hfh66anHvawWJmZ3aKgjB6yZhQX3pwmDbjUHLKWCkoNUpfqkp9KM5Ypcxx_fskYyFlqajQH4vzGDeU0qo26qzo1z2QHcKTG2D0QNzYEj8hwuAStARDfCSd82nCSKaOOMT-kPptcCSMZOdSgDFF8hxST3yP0xg8iYeYpiGDv9GyOgx7hIvitHNDhE__5qK4_361Xt6Uq7vr2-XXVdnwnLqsuQRRc2M6yTVtOgdatFBzaJlxoqGSt961nnfGG9Mqr6u6AcO4yN8YI7VYFJ_nuzuc_uwhJruZ9jhmS8u0oZoZKUVmmZnlcYoRobM7DFuHB8uoPfZq33q1x17t3KvNCbO0nKUhJnh51zl8tEoLLe2Ph6Wt1fr65-pXZb9lvpj5zXbz_y6vJ42O_Q</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Shengbo, Yu</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201110</creationdate><title>The prevalence and correlated risk factors of arrhythmia in patients with chronic systolic heart failure</title><author>Shengbo, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2646-925e39288f5270bfae73de92ed18a3b052dcadc2f8c88d6c749be812398688573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shengbo, Yu</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shengbo, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevalence and correlated risk factors of arrhythmia in patients with chronic systolic heart failure</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>2011-10</date><risdate>2011</risdate><volume>97</volume><issue>Suppl 3</issue><spage>A220</spage><epage>A221</epage><pages>A220-A221</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract><![CDATA[Objective To investigate the prevalence of arrhythmia in patients with chronic systolic heart failure (CSHF) in Hubei province and analyse the correlation between atrial fibrillation (AF), premature ventricular contracts (PVCs), ventricular tachycardia (VT) and age, NYHA heart function classification, left ventricular ejection fraction (LVEF), aetiology, respectively. Methods Data of in-hospital patients with CSHF were investigated between 2000 and 2010 from 12 hospitals in Hubei Province. Univariate and multivariate logistic proportional hazard analysis were performed to determinate the relationships between AF, PVCs, VT and age, NYHA heart function classification, LVEF, aetiology, respectively. Results (1) PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF which account 68.30%, 40.81%, 21.16% and 14.50%, respectively. (2) The HRs (95% CI) of AF for patients in 40–50, 50–60, 60–70, 70–80 and ≥80 age were 1.670 (1.237 to 2.253, p<0.01), 2.315 (1.759 to 3.047, p<0.01), 3.103 (2.368 to 4.067, p<0.01), 3.805 (2.911 to 4.972, p<0.01) and 5.018 (3.771 to 6.676, p<0.01), respectively, compared with patients in <40 years group. While there were no significant difference among different age groups in HR of PVCs and VT in multivariate logistic analysis. (3) The HRs (95% CI) of AF or VT for patients in LVEF 31–40%, 21–30% and ≤20% group were 1.565 (1.446 to 1.717, p<0.01), 1.640 (1.225 to 1.923, p<0.01) and 2.104 (1.925 to 2.223, p<0.01), respectively; 1.760 (95% CI 1.218 to 2.345, p<0.01), 2.396 (95% CI 2.019 to 2.783, p<0.01) and 4.209 (95% CI 3.554 to 4.862, p<0.01), respectively, compared with patients in LVEF 41–50% group. However, there is no significant difference among different LVEF groups in HR of PVCs in multivariate logistic analysis. (4) The HRs (95% CI) of AF, PVCs and VT for patients with dilated cardiomyopathy, hypertension heart disease or valvular heart disease were 1.876 (1.608 to 2.188, p<0.01), 1.297 (1.132 to 1.486, p<0.01) and 12.111 (9.820 to 14.937, p<0.01), respectively; 1.143 (1.082 to 1.224, p<0.01), 0.559 (0.322 to 0.743, p<0.01) and 0.896 (0.775 to 1.211, p=0.358), respectively; 1.189 (95% CI 1.096 to 1.284, p<0.01), 0.430 (95% CI 0.381 to 0.497, p<0.01) and 0.530 (95% CI 0.421 to 0.652, p<0.01), respectively, compared with patients in coronary heart disease group. Conclusions PVCs, AF, atrial tachycardia and VT are the common arrhythmia in patients with CSHF. The risk of AF morbidity increases as age increases or LVEF decreases and varies in patients with different aetiology. The risk of PVCs morbidity varies in patients with different aetiology while was not affected by age, NYHA or LVEF. The risk of VT morbidity increases as LVEF decreases and is different in patients with different aetiology.]]></abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><doi>10.1136/heartjnl-2011-300867.646</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-6037
ispartof Heart (British Cardiac Society), 2011-10, Vol.97 (Suppl 3), p.A220-A221
issn 1355-6037
1468-201X
language eng
recordid cdi_proquest_journals_1780718553
source BMJ Journals - NESLi2; PubMed Central
title The prevalence and correlated risk factors of arrhythmia in patients with chronic systolic heart failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T21%3A33%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevalence%20and%20correlated%20risk%20factors%20of%20arrhythmia%20in%20patients%20with%20chronic%20systolic%20heart%20failure&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Shengbo,%20Yu&rft.date=2011-10&rft.volume=97&rft.issue=Suppl%203&rft.spage=A220&rft.epage=A221&rft.pages=A220-A221&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/heartjnl-2011-300867.646&rft_dat=%3Cproquest_cross%3E4020986811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780718553&rft_id=info:pmid/&rfr_iscdi=true